key: cord-0775852-d6tr8sph
authors: Bellmann-Weiler, Rosa; Lanser, Lukas; Burkert, Francesco; Seiwald, Stefanie; Fritsche, Gernot; Wildner, Sophie; Schroll, Andrea; Koppelstätter, Sabine; Kurz, Katharina; Griesmacher, Andrea; Weiss, Günter
title: Neopterin predicts disease severity in hospitalized patients with COVID-19
date: 2020-11-03
journal: Open Forum Infect Dis
DOI: 10.1093/ofid/ofaa521
sha: 152a95dc377e67a4f6c0fdae0682c47d583bfd44
doc_id: 775852
cord_uid: d6tr8sph

This study evaluates the predictive value of circulating inflammatory markers, especially neopterin, in patients with COVID-19. Within this retrospective analysis of 115 hospitalized COVID-19 patients, elevated neopterin levels upon admission were significantly associated with disease severity, risk for ICU admission, need for mechanical ventilation and death. Therefore, neopterin is a reliable predictive marker in patients with COVID-19 and may help to improve the clinical management of patients.

M a n u s c r i p t

The novel pandemic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing challenge for health care systems worldwide (1) . While most subjects experience a mild course of the infection, between 15 to 20% need hospitalization mostly because of shortness of breath, and hypoxia on the basis of infection induced pneumonia. During hospitalization some patients deteriorate, then needing non-invasive ventilation or intensive care unit (ICU) admission with the need for mechanical ventilation. While age, male gender and pre-existing co-morbidities along have been found to increase the risk for a complicated course or death from the disease, no single biomarker has been found which identifies patients at risk when admitted to the hospital (2, 3) . Therefore, besides the clinical presentation, reliable and easily available parameters allowing to predict the course and to plan optimal treatment are urgently needed. Viral infection stimulates the formation of interferon gamma (IFN-γ) which activates monocytes and macrophages to produce the pteridine neopterin, which is an established biomarker in viral infection, but neopterin is also increased in other diseases involving activation of cellular immune function (4) (5) (6) . Neopterin in combination with C-reactive protein (CRP) allows a differentiation between viral and bacterial respiratory infections (7, 8) . Moreover, high neopterin levels were associated with a worse outcome in different viral infections (9) (10) (11) . Although, increased IL-6 levels were shown to be associated with a cytokine storm in COVID-19 patients and being predictive for an increased risk of respiratory failure and death, IL-6 determination does not provide information on its source since multiple cells and tissues can produce this protein (12) . In contrast, neopterin is exclusively produced by monocytic cells in response to stimulation by the T-helper cell type 1 (Th1) derived cytokine IFN-γ, thereby providing information on the degree of cell mediated immune activation in the setting of a specific disease (13) . We thus studied if neopterin either alone or in combination of other established markers of inflammation such as CRP, procalcitonin (PCT) or M a n u s c r i p t interleukin-6 (IL-6) may be of value to predict the clinical course of hospitalized patients with SARS-CoV-2 infection.

We retrospectively analyzed data and medical reports of 124 consecutive patients who were 

This study conformed to the principles outlined in the Declaration of Helsinki and was approved by the ethics committee of the Innsbruck Medical University (ID of ethical vote: 1167/2020). All patients gave written informed consent.

Blood samples were analyzed with fully automated tests in the Central Institute for Medical and Chemical Laboratory Diagnosis of the Innsbruck University Hospital, which undergoes regular internal and external quality controls and evaluations. Laboratory parameters were then extracted from the KIS for day 1 ± 1, day 4 ± 1 and day 7 ± 1 since hospitalization if available.

A c c e p t e d M a n u s c r i p t Neopterin was routinely measured with an enzyme-linked immunosorbent assay (ELISA) (Magellan BioScience Group, Tampa, USA). As neopterin was shown to be higher in patients with reduced kidney function (5, 14) , the routinely estimated glomerular filtration rate (eGFR) with the CKD-EPI formula was taken to calculate the ratio of neopterin/eGFR. IL-6 was detected with an electrochemiluminescence immunoassay on a Cobas8000 C602 analyzer (Roche Diagnostics GmbH, Mannheim, Germany). CRP concentrations were measured with an immunoturbidimetric assay on a Cobas8000 C702 analyzer (Roche Diagnostics GmbH, Mannheim, Germany). PCT was detected with an electrochemiluminescense immunoassay on a Cobas8000 C602 analyzer (Roche Diagnostics GmbH, Mannheim, Germany).

We used the Shapiro-Wilk test to test for Gaussian distribution. Parameters are depicted as n (%) or medians (25 th , 75 th percentile), since they were not normally distributed. Mann-Whitney-U test, Kruskal-Wallis test or Pearson chi-square tests were performed to test for significant differences between groups. Logistic regression analysis was performed to analyze the effects of risk factors on probability of ICU admission or need for assisted ventilation. Not normally distributed parameters were logarithmized with the natural logarithm for the logistic regression analysis. Only parameters with significance in the univariate logistic regression analysis were considered for multivariate logistic regression analysis. All tests were two tailed and p-values < 0.05 were regarded as Taking into account the severe stress of ICU treatment with highly invasive ventilation and sedation described in literature and seen in real life at our clinics, and the multiple risk factors and comorbidities of elderly patients associated with a fatal outcome, we aimed at an early stratification.

Because of the limited benefit for them, such elderly multi-morbid patients were eventually not referred to ICU (15) . Therefore, to estimate the predictive potential of the markers under investigation for ICU admission or the need of mechanical ventilation only patients below the age of c c e p t e d M a n u s c r i p t multivariate logistic regression analysis, and also true when correcting neopterin levels for renal function by calculating a neopterin/eGFR ratio ( Table 2 ).

In being produced by cytokine IFN-γ the macrophage derived pteridine neopterin has become an established marker in different viral infections including HIV and influenza where it was linked to disease activity, prediction of their clinical course and for differentiation from bacterial infections (8) (9) (10) (11) . In addition, neopterin levels corresponded to severity and outcome of different infectious and/or inflammatory diseases (10, 11) .

To our knowledge this is the first study which evaluated neopterin in SARS-CoV-2 infection and demonstrates its important clinical and predictive potential in this infection. Neopterin levels above 45 nmol/L allow early identification of hospitalized patients at risk of requirement for mechanical ventilation and ICU treatment even upon admission, indicating a severe and prolonged course of infection. Though neopterin levels decrease over time, which may be attributed to diminished viral activity even in patients under mechanical ventilation and resolution of inflammation as evidenced by parallel reduction of IL-6 levels (16) . The association of high neopterin levels with an increased risk of need of mechanical ventilation, ICU treatment and adverse outcome recommends neopterin as reliable parameter for predicting the prognosis of SARS-CoV-2 infected patients and to adapt the treatment algorithm for such patients with an increased risk of adverse outcome. Specifically, patients with high neopterin levels at initial presentation need intensified monitoring and likewise early referral to non-invasive ventilation to reduce the likelihood for mechanical ventilation and ICU admission which is associated with potential complications and long-term care. The association of high neopterin with an adverse clinical course is in line with the idea that more advanced, T cell triggered immune activation is a major driver for an adverse outcome. The diagnostic benefit of neopterin over IL-6 is due to the fact that neopterin is induced by the Th-1 cytokine IFN-, thereby A c c e p t e d M a n u s c r i p t more specifically reflecting a T-helper cell type 1 derived immune activation and stimulation of monocytic cell effector functions. This is in a line with recent observations demonstrating that T-cell activation plays an important role for triggering severe pulmonary inflammation and impaired ventilation in SARS-CoV-2 infections (17, 18) . However, our results indicate that already at initial presentation of COVID-19 patients needing hospitalization, both the IFN-γ pathway and the acute phase response of the immune system as reflected by IL-6 are already activated and predict the response of the subsequent clinical course (19) .

A limitation of our study is that we have not evaluated baseline radiographic features by computed tomography. Therefore we cannot provide information whether or not increased neopterin levels are linked more pronounced pathologic alterations on such images.

This research received no external funding.

The authors declare no conflict of interest. M a n u s c r i p t Tables   Table 1 Baseline M a n u s c r i p t 

COVID-19: towards controlling of a pandemic

Clinical Characteristics of Covid-19 in China

Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Biochemistry and Clinical Use as a Marker for Cellular Immune-Reactions

Neopterin is Associated with Disease Severity and Outcome in Patients with Non-Ischaemic Heart Failure

Neopterin as a marker for activated cell-mediated immunity: application in malignant disease

Clinical potential of C-reactive protein and procalcitonin serum concentrations to guide differential diagnosis and clinical management of pneumococcal and Legionella pneumonia

Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations

Neopterin levels and Kyn/Trp ratios were significantly increased in dengue virus patients and subsequently decreased after recovery

Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption

IFNgamma mediated pathways in patients with fatigue and chronic active Epstein Barr virusinfection

Confronting the controversy: Interleukin-6 and the COVID-19 cytokine storm syndrome

Neopterin, biochemistry and clinical use as a marker for cellular immune reactions

Determination of renal clearance of neopterin by a pharmacokinetic approach

Early Intervention of Palliative Care in the Emergency Department During the COVID-19 Pandemic

SARS-CoV-2: a storm is raging

The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Regulation of IL-6 in Immunity and Diseases

A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t